Amanote Research

Amanote Research

    RegisterSign In

Opicapone: Once-Daily Adjunctive Therapy for Parkinson's Disease

Prescriber - United Kingdom
doi 10.1002/psb.1543
Full Text
Open PDF
Abstract

Available in full text

Categories
Pharmacology
Date

February 1, 2017

Authors
Steve Chaplin
Publisher

Wiley


Related search

Once-Daily Gentamicin Therapy for Experimental Escherichia Coli Meningitis.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1997English

Tolcapone: Review of Its Pharmacology and Use as Adjunctive Therapy in Patients With Parkinson's Disease

Clinical Interventions in Aging
MedicineGerontologyGeriatrics
2009English

Metabotropic Glutamate Receptors for Parkinson's Disease Therapy

Parkinson's Disease
PsychiatryNeuroscienceMental HealthNeurology
2013English

Mesenchymal Stem Cell Based Therapy for Parkinson's Disease

International Journal of Stem Cell Research & Therapy
2019English

Comparison of Once Daily Versus Twice Daily Olmesartan in Patients With Chronic Kidney Disease

International Journal of Nephrology and Renovascular Disease
Nephrology
2013English

Functional Neurosurgery in Parkinson's Disease Therapy

BMC Geriatrics
GerontologyGeriatrics
2010English

Inflammation: Role in Parkinson's Disease and Target for Therapy

2016English

Tularemia and Once-Daily Gentamicin

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2006English

Adjunctive Therapy for Myofascial Pain Syndrome

Journal of Musculoskeletal Pain
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy